These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 15075910)

  • 1. Management of brain metastases in patients with melanoma.
    Tarhini AA; Agarwala SS
    Curr Opin Oncol; 2004 Mar; 16(2):161-6. PubMed ID: 15075910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapeutic strategies and systemic treatment of brain melanoma metastases].
    Durando X; Mansard S; Daste A; Gimbergues P; Brocard L; Magné N; Thivat E
    Bull Cancer; 2013 Jan; 100(1):23-8. PubMed ID: 22889847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Melanoma brain metastases : Treatment options].
    Rauschenberg R; Tabatabai G; Troost EG; Garzarolli M; Beissert S; Meier F
    Hautarzt; 2016 Jul; 67(7):536-43. PubMed ID: 27206449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melanoma in the brain: biology and therapeutic options.
    Gibney GT; Forsyth PA; Sondak VK
    Melanoma Res; 2012 Jun; 22(3):177-83. PubMed ID: 22495668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-dense temozolomide regimen for the treatment of brain metastases from melanoma, breast cancer, or lung cancer not amenable to surgery or radiosurgery: a multicenter phase II study.
    Siena S; Crinò L; Danova M; Del Prete S; Cascinu S; Salvagni S; Schiavetto I; Vitali M; Bajetta E
    Ann Oncol; 2010 Mar; 21(3):655-661. PubMed ID: 19767314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temozolomide for the treatment of brain metastases associated with metastatic melanoma: a phase II study.
    Agarwala SS; Kirkwood JM; Gore M; Dreno B; Thatcher N; Czarnetski B; Atkins M; Buzaid A; Skarlos D; Rankin EM
    J Clin Oncol; 2004 Jun; 22(11):2101-7. PubMed ID: 15169796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy of malignant melanoma at the stage of distant metastasis].
    Garbe C; Eigentler TK
    Hautarzt; 2004 Feb; 55(2):195-213. PubMed ID: 15043023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiotherapy and immunotherapy: Can this combination change the prognosis of patients with melanoma brain metastases?
    Franceschini D; Franzese C; Navarria P; Ascolese AM; De Rose F; Del Vecchio M; Santoro A; Scorsetti M
    Cancer Treat Rev; 2016 Nov; 50():1-8. PubMed ID: 27566962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival over 6 years in a patient with brain metastases from melanoma treated with temozolomide.
    Koekkoek JA; Wiggenraad RG; Zwinkels H; Oosterkamp HM; Taphoorn MJ
    BMJ Case Rep; 2012 Sep; 2012():. PubMed ID: 23008380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temozolomide with or without radiotherapy in melanoma with unresectable brain metastases.
    Hofmann M; Kiecker F; Wurm R; Schlenger L; Budach V; Sterry W; Trefzer U
    J Neurooncol; 2006 Jan; 76(1):59-64. PubMed ID: 16132502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment options for brain metastases from melanoma.
    McWilliams RR; Rao RD; Brown PD; Link MJ; Buckner JC
    Expert Rev Anticancer Ther; 2005 Oct; 5(5):809-20. PubMed ID: 16221051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temozolomide in advanced malignant melanoma with small brain metastases: can we withhold cranial irradiation?
    Boogerd W; de Gast GC; Dalesio O
    Cancer; 2007 Jan; 109(2):306-12. PubMed ID: 17149755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors for overall survival after radiosurgery for brain metastases from melanoma.
    Marcus DM; Lowe M; Khan MK; Lawson DH; Crocker IR; Shelton JW; Melton A; Maynard N; Delman KA; Carlson GW; Rizzo M
    Am J Clin Oncol; 2014 Dec; 37(6):580-4. PubMed ID: 23428955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of survival rates for treatment of melanoma metastatic to the brain.
    Stone A; Cooper J; Koenig KL; Golfinos JG; Oratz R
    Cancer Invest; 2004; 22(4):492-7. PubMed ID: 15565805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemotherapy of metastatic melanoma in patients with or without recently diagnosed brain metastases.
    Majer M; Jensen RL; Shrieve DC; Watson GA; Wang M; Leachman SA; Boucher KM; Samlowski WE
    Cancer; 2007 Sep; 110(6):1329-37. PubMed ID: 17623835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Complete response of cerebral metastasic melanoma after a combined treatment of radiotherapy and temozolomide].
    Conill C; Puig S; Toscas I; Castel T
    Med Clin (Barc); 2002 Nov; 119(19):758-9. PubMed ID: 12487980
    [No Abstract]   [Full Text] [Related]  

  • 17. Temozolomide, thalidomide, and whole brain radiation therapy for patients with brain metastasis from metastatic melanoma: a phase II Cytokine Working Group study.
    Atkins MB; Sosman JA; Agarwala S; Logan T; Clark JI; Ernstoff MS; Lawson D; Dutcher JP; Weiss G; Curti B; Margolin KA
    Cancer; 2008 Oct; 113(8):2139-45. PubMed ID: 18792064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Update on cerebral tumors].
    Benouaich-Amiel A; Delattre JY
    Bull Cancer; 2006 Jan; 93(1):73-81. PubMed ID: 16455509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiotherapy for metastatic brain tumors.
    Shibamoto Y; Sugie C; Iwata H
    Int J Clin Oncol; 2009 Aug; 14(4):281-8. PubMed ID: 19705237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival and prognostic factors in patients with brain metastases from malignant melanoma.
    Meier S; Baumert BG; Maier T; Wellis G; Burg G; Seifert B; Dummer R
    Onkologie; 2004 Apr; 27(2):145-9. PubMed ID: 15138346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.